Founders & Management
Our exceptional team at Sur180 comprises distinguished biomedical professionals with a decade of experience in endometriosis care. From gastrointestinal physiology to clinical pharmacology, our founders bring together a wealth of expertise to redefine the treatment landscape for endometriosis.
Annelyn Torres-Reveron, Ph.D.
Co-Founder & CEO
-
Behavioral Neuroscientist
-
Certified in Integrative Medicine
-
Pitch Academy UTRGV
-
iCorps training MD Anderson Cancer Center
-
UW Biotechnology Program Management
-
PRST & Columbia University Therapeutics Accelerator Program
Caroline B. Appleyard, Ph.D.
Co-Founder & Scientific Director
-
Clinical Pharmacologist
-
Translational Research using Animal Models
-
Oversight of Training Programs (NIGMS & NCI)
-
NIH Introduction to the Principles and Practice of Clinical Research
-
PRST & Columbia University Therapeutics Accelerator Program
Idhaliz Flores, Ph.D.
Co-Founder & Chair of Scientific Board
-
Molecular Biologist
-
Board of Directors, ENDOPR
-
PI Integrative Multimodal Intervention (NICHD)
-
Endometriosis patient advocate
I2P Ideas to Product Xcelerator network (NIGMS)
Sur180 Staff
Jaydie Valles
Research Associate and main laboratory technician for Sur180 Therapeutics at the Ponce Research Institute Labs in Ponce, PR. Jaydie has been working with Sur180 since the company's inception in 2021.
José Pagán
Research Assistant. He is responsible for assisting with laboratory procedures and pre-clinical experimentation. Jose has a significant interest in translational science and aspires to become a medical doctor.
Luis A. Rivera-Arce, PhD
Research coordinator. Luis joined Sur180 Therapeutics in July 2025. With significant experience in endometriosis and gastrointestinal physiology, he oversees GLP alignment and database management. He also coordinates communications across multiple stakeholders.
Myrella L. Cruz
Myrella is the main laboratory supervisor at our collaborative institution Ponce Research Institute. Myrella brings more than 20 years of experience in preclinical research and has mentored numerous aspiring scientists. She also serves as Archivist for GLP studies at Sur180.
Board Members & Advisors
Ignacio Pino, DVM,
Board Member &
Entrepreneurial Advisor
Ignacio Pino, DVM advises Sur180 Therapeutics in areas such as fundraising and commercialization leveraging his experience as co-founder of CDI Labs, Mayaguez, PR, where he currently serves as COO.
Lissette Gutierrez, MD.
Board Member &
Principal Clinical Adviser
With over 20 years of experience in obstetrics and gynecology, she is a highly trusted clinician with expertise in sexual health, endometriosis, and complex pelvic pain. She currently serves as a Medical Science Liaison at Novo Nordisk, focused on rare renal disorders.
Carolyn Sikes, PhD
Regulatory Advisor
Carolyn has a background in neuroscience/psychoneuroendocrinology with a PhD from Duke University and a post-doctoral fellowship from Cornell University Medical College. She is a seasoned drug development and medical affairs expert, with over 30 years of experience in multiple therapeutic areas.
Development Partners
Join Our Newsletter
Join our newsletter for updates on our work and progress.